Product Catalog
Home >


Anti-SARS-Cov-2 Rapid Test, COVID-19, 50 tests per kit, by AutoBio Diagnostics Co., Ltd.

Product is not available for on-line ordering. Please contact your Hardy Sales Representative for further information or to set up an account. If you already have an active account with us, you can also place an order immediately by contacting Customer Service directly.

The new tentative ship date is now May 5th. However, we will certainly update you when more information becomes available.

This product is not available for purchase and resale by our distributor partners.

Intended for the presumptive detection of IgG and IgM antibodies from the SARS-CoV-2 virus in plasma, serum, or capillary finger prick blood from individuals with signs and symptoms of COVID-19 infection. PK 50 (50 tests per kit)

One of the world’s first rapid lateral flow immunoassays for the diagnosis of COVID-19 disease. This kit is CE Marked-IVD. This test detects both early marker (IgM) and late marker (IgG) antibodies in human finger-prick (capillary), serum, and plasma samples, from anticoagulated blood.

The test can be used for rapid screening of carriers of the virus that are symptomatic or asymptomatic. Recent studies suggest that a high percentage of patients show no clinical symptoms of the virus, thus screening patients is vitally important. The test is ideally suited for hospitals and testing laboratories that perform highly complex testing.

The Anti-SARS-Cov-2 Rapid Test can be used to screen patients suspected of having been infected by the novel coronavirus. However, results of test should not be the only basis for diagnosis. Results should be used in combination with clinical observations and other testing methods such as nucleic acid PCR test.

Features and Benefits

  • Results in 15 minutes
  • No special equipment or facilities needed.
  • Easy-to-interpret results.
  • Built-in-controls
  • Room temperature storage
  • Sensitivity - 97.4%
  • Specificity - 96.2%

    Hardy Diagnostics has permission to sell this test under the FDA’s Emergency Use Authorization (EUA) program , which is currently under review. Please note the following information:

    • This test has not been reviewed by FDA
    • Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in recent contact with the virus, due to the lag time between exposure and the patient’s antibody response. Follow-up testing with a molecular diagnostic test should be considered in order to rule out infection in these individuals.
    • Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform of infection status.
    • Positive results may be due to past or present infections with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43 or 229E.
    • Not to be used for blood donor screening


  • To order this product, enter the quantity you wish to order in the QTY field and click the shopping cart icon. When finished, click My Shopping Cart to proceed to checkout or Continue Shopping to shop for more products.

    Cat No. Description Price Curr UOM
    RTA0203 Anti-SARS-CoV-2 Rapid Tes
    AutoBio, 50 tests
    $497.50 USD EA

    Manufacturer Category Organism
    AutoBio Diagnostics Co., Ltd.

    Rapid ID Test Kits

    N/A

    Instructions for Use Video SDS


    N/A



    Brochures and Studies BioSafety Level




    N/A

    Related Products
    331110 Pipet, Adjustable, Diamond Line, autoclavable portions, 0.5-10µl, red, 1 each, by Globe Scientific
    P3989 Pipette stand, holds 5 pipets, by National Labnet
    T300RS Pipet Tips, 0.5-10µl, clear, sterile, rack pack, 4800 per case, by Corning Life Sciences